CPNG Record Margins, a Record Stock Price, and a Buyback Still Sitting Untouched

The Best Operating Quarter on Record, Funded by a Widening Cash Gap

Coupang's second quarter of 2025 is the strongest set of headline numbers this site has covered for the company: total net revenues grew 16.4% YoY to $8.524 billion, Adjusted EBITDA^» rose 30% to $428 million - a record 5.0% margin - and Product Commerce's segment margin hit an all-time high of 9.04%, beating Q2 2024's previous record of 8.24% and comfortably clearing Q1 2025's 8.0%. Net income attributable to Coupang stockholders reversed to $32 million from a $77 million loss a year earlier. On the income statement alone, this is Coupang's cleanest quarter yet.

It doesn't stay that clean once the cash flow statement gets a look. Free cash flow^» fell 49% YoY to $247 million, and operating cash flow itself declined 18% to $545 million - both moving the opposite direction from Adjusted EBITDA's 30% climb. The reason is straightforward and disclosed plainly: capital expenditure on new fulfillment centers nearly doubled to $538 million from $285 million a year ago, and the company says this is only the start of a multi-year build-out ("future expenditures for both infrastructure and workforce-related costs will exceed several billion dollars over the next several years," per this filing). That's not inherently a problem - a scaling logistics network legitimately front-loads capex ahead of the revenue it enables - but it means the record Adjusted EBITDA number and the record free-cash-flow decline are both real, and a reader focused only on the first would miss the second entirely. See Beyond the Usual below for how this connects to the untouched buyback and the new debt facility.

The Prescription

Coupang should keep publishing the same capex disclosure it gave this quarter - naming the multi-year fulfillment-center build-out explicitly and quantifying the committed spend ($374 million in remaining construction contracts as of this filing) - rather than letting a widening gap between Adjusted EBITDA growth and free cash flow speak for itself. A reader who only tracks the adjusted metric would see a record quarter; a reader who tracks cash would see the fourth straight quarter of rising capex outrunning operating cash generation (trailing-twelve-month free cash flow is now down 48% YoY, from $1.513 billion to $784 million). Both things are true, and the company is disclosing the inputs honestly - it should keep doing exactly that, quarter over quarter, so the buildout doesn't quietly become the story only in hindsight.

What it should stop doing: authorizing headline capital-return programs it doesn't use in the same breath as citing "several billion dollars" of committed future capex. The $1 billion buyback authorized in May 2025 went entirely unused this quarter - not a single share was repurchased. Announcing a buyback authorization generates a market reaction (see Target Valuation Range below for how much the stock moved this quarter) whether or not it's ever executed; if capex is about to consume "several billion dollars... over the next several years," as this filing says, the buyback reads more like a signaling device than a real capital-allocation plan until Coupang actually uses it.

Key Financial Metrics

Q2 2025 vs. Q2 2024 - reported in USD, figures from this 10-Q's condensed consolidated financial statements

Coupang reports natively in US dollars, so no FX conversion is needed here. Figures are drawn directly from this Form 10-Q's condensed consolidated financial statements and MD&A tables, covering the quarter ended June 30, 2025.

Metric	Q2 2025	Q2 2024	YoY
Total net revenues	$8,524M	$7,323M	✅ +16.4%
Gross profit	$2,561M	$2,142M	✅ +19.6%, margin 30.0% vs 29.3%
Operating income (loss)	$149M	$(25)M	✅ reversed to a profit
Adjusted EBITDA»	$428M	$330M	✅ +30%, record 5.0% margin vs 4.5%
Income before income taxes	$194M	$3M	✅ up sharply
Income tax expense	$163M	$108M	⚠️ +51%, effective rate 84.0% vs non-meaningful
Net income (loss) (consolidated)	$31M	$(105)M	✅ reversed to a profit
Net income (loss) attributable to Coupang stockholders	$32M	$(77)M	✅ reversed to a profit
Net cash provided by operating activities	$545M	$664M	⚠️ -18%
Free cash flow»	$247M	$488M	⚠️ -49%
Cash & cash equivalents (period end)	$6,796M	-	vs $5,879M at Dec 2024

Balance sheet metric	Jun 2025	Dec 2024	Change
Total assets	$17,831M	$15,344M	✅ +16.2%
Total liabilities	$13,146M	$11,167M	⚠️ +17.7%
Total equity	$4,685M	$4,102M	✅ +14.2%
Redeemable noncontrolling interest	$0M	$75M	✅ eliminated, following Greenoaks' full exit - see below

Total short- and long-term debt (short-term borrowings, current portion of long-term debt, and long-term debt) rose to $1.804 billion at quarter-end from $1.533 billion at year-end, still modest relative to the balance sheet, though this doesn't yet reflect the $425 million drawn in July 2025 to redeem the Farfetch Term Loans - see Beyond the Usual. Capital expenditure (purchases of property and equipment) nearly doubled to $538 million from $285 million a year ago (see above). Long-term operating lease obligations rose 28.2% to $2.270 billion from $1.770 billion, continuing the fulfillment-center expansion pattern flagged in prior quarters.

The effective tax rate of 84.0% remains far above the U.S. statutory rate - Q2 2024's comparison is "non-meaningful" because pre-tax income was only $3 million that quarter, swamped by the $121 million KFTC fine. This is the same structural pattern this site has tracked since that fine's accrual made a large slice of Coupang's tax expense non-deductible; nothing in this filing suggests it's changed. Separately, the "One Big Beautiful Bill Act" was enacted in the U.S. on July 4, 2025 - a subsequent event - introducing international tax-framework changes Coupang says are not yet incorporated into this quarter's figures.

Segment Performance: Product Commerce vs. Developing Offerings

Coupang reports the same two segments as every quarter since Q1 2022: Product Commerce (core retail, marketplace, Rocket Fresh, and related advertising) and Developing Offerings (Coupang Eats, Coupang Play, Taiwan retail, fintech, and Farfetch).

Metric	Product Commerce Q2 2025	Product Commerce Q2 2024	Developing Offerings Q2 2025	Developing Offerings Q2 2024
Net revenues	$7,334M	$6,431M	$1,190M	$892M
Revenue growth	✅ +14.0%	—	✅ +33.4%	—
Segment Adjusted EBITDA	✅ $663M (margin 9.04%)	$530M (margin 8.24%)	⚠️ $(235)M (margin -19.75%)	$(200)M (margin -22.42%)

Product Commerce set a new all-time high segment margin at 9.04%, beating the previous record of 8.24% set in Q2 2024 and well clear of Q1 2025's 8.0% - confirming the segment's profitability keeps stepping up rather than plateauing in the high-7s/8% range this site flagged last quarter. Revenue growth of 14.0% is also a reacceleration from Q1 2025's 5.8%, the segment's slowest quarter in the trailing year - so both the growth deceleration flagged last quarter and the margin ceiling both reversed in the same quarter.

Developing Offerings' loss widened 17.5% YoY in dollar terms to $(235) million, even as the margin improved YoY (from -22.42% to -19.75%) on 33.4% revenue growth - both patterns consistent with Farfetch maturing inside the segment. But the margin actually worsened sequentially, from Q1 2025's -16.2% to this quarter's -19.75% - a reminder that the improving YoY trend isn't a straight line quarter to quarter.

Key Operational Metrics

Quarter	Product Commerce Active Customers	Net revenues per Product Commerce Active Customer
Jun 2024	21.7M	$296
Sep 2024	22.5M	$307
Dec 2024	22.8M	$302
Mar 2025	23.4M	$294
Jun 2025	23.9M	$307

Product Commerce Active Customers^» grew 10% YoY to a new high of 23.9 million, adding 0.5 million sequentially. Net revenues per Product Commerce Active Customer^» recovered to $307 - matching September 2024's prior high - up 4% YoY nominal and 6% on a constant-currency basis, a smaller currency drag than Q1 2025's gap between its 6% constant-currency and roughly flat nominal figure. Read together: customer growth held at double digits and, unlike last quarter, per-customer spend grew in both nominal and constant-currency terms - the currency headwind eased rather than fully offsetting engagement gains.

"Not available" again this filing: orders per customer, Rocket WOW membership subscriber count, and third-party seller/merchant count - none disclosed, consistent with every prior quarter this site has tracked.

The Stock Rallied 37% in a Quarter That Also Delivered the Numbers to Support It

Coupang closed Q2 2025 (June 30, 2025) at $29.96, up 36.6% from Q1 2025's close of $21.93 and up 43.0% from a year earlier. That's a large enough single-quarter move to warrant its own section rather than folding straight into valuation - over the trailing two years the stock ranged from a low near $14 (January 2024) to this quarter's close near $30, more than doubling peak-to-trough. Unlike some of the stock's past moves, this one arrived in the same quarter as the strongest operating numbers this site has tracked for the company - record Adjusted EBITDA margin, record Product Commerce segment margin, and reaccelerating revenue growth - so it reads less like pure multiple expansion and more like the market catching up to results, even before accounting for the still-unused buyback authorization (see Beyond the Usual).

Beyond the Usual

A $1 billion buyback authorization went entirely unused in its first full quarter

Coupang's Board authorized a $1 billion stock repurchase program in May 2025, its first standing buyback since an April 2024 one-off private-transaction repurchase. This filing confirms no shares of Class A common stock were repurchased during the three or six months ended June 30, 2025 - the authorization's first full quarter produced zero execution. The program has no expiration date and no obligation to repurchase any specific amount, so this isn't a broken promise, but it means the capital-return signal the market may have priced in when the authorization was announced hasn't yet translated into an actual reduction in share count. Worth tracking whether the next filing shows the same pattern.

A new revolving credit facility replaced the 2021 one, then got drawn down within weeks to retire the Farfetch acquisition debt

In June 2025, Coupang entered a new five-year, $1.5 billion syndicated, unsecured revolving credit agreement, terminating the prior revolving credit and guaranty agreement it had held since February 2021. No balance was outstanding on the new facility as of June 30, 2025. As a subsequent event, Coupang borrowed $425 million under the new facility in July 2025 specifically to redeem the "Farfetch Term Loans" - the syndicated debt Surpique LP (the Farfetch acquisition vehicle) assumed as part of the January 2024 deal, which stood at $392 million outstanding as of this quarter-end. The filing states those term loans were "fully redeemed" using the new facility's proceeds. Read together with the balance-sheet debt figures above, this doesn't reduce Coupang's total debt - it swaps Farfetch-specific acquisition debt for a draw on Coupang's own general corporate credit line - but it does simplify the capital structure, retiring a syndicated loan tied to a specific deal in favor of the company's own revolver. A detail a reader wouldn't see just from this quarter's own balance sheet, since the redemption happened after quarter-end.

The KFTC's administrative case is now four hearings deep with no ruling, while the criminal indictment gets its first hearing date

The KFTC administrative appeal tracked since Q4 2024 has now had hearings in November 2024, March 2025, June 2025, and July 2025, with a fifth hearing scheduled for September 2025 - four hearings deep with no ruling on the underlying product-rankings finding. Separately, the criminal indictment issued against Coupang Corp. and CPLB as a subsequent event last quarter now has its first hearing scheduled for October 2025. The maximum penalty under the indictment remains a fine of approximately $200,000 - still trivial next to the $121 million administrative fine already being paid in installments - and Coupang continues to state it has "substantial defenses" and intends to "vigorously defend" the charges. The stockholder derivative actions and Board demands disclosed in prior quarters are unchanged this filing - no new suits, no new demands, and still no lead plaintiff named in the underlying Choi v. Coupang securities class action.

Coupang entered new unconditional purchase obligations totaling $668 million with remaining payments through 2033 during the six months ended June 30, 2025 - roughly double the $328 million disclosed for Q1 2025 alone - primarily technology services, fulfillment-center construction, and content/software licensing commitments, consistent with the capex buildout flagged above. None of it shows up on the balance sheet today, but it's a real multi-year commitment layered on top of what was already disclosed last quarter.

Coupang's own liquidity disclosure this quarter puts a number on part of that buildout directly: $374 million in remaining capital-expenditure commitments under construction contracts for new fulfillment centers "expected to be completed over the next two years" - a rare instance of the company quantifying its own forward capex plan rather than describing it only in general terms.

Target Valuation Range

EV $49.5 billion, ~1.53x EV/Revenue. Bottom line: Coupang's EV/Revenue multiple rose to roughly 1.53x trailing-twelve-months, up from Q1 2025's ~1.13x - the market re-rated the stock meaningfully this quarter, and the operating numbers above suggest that re-rating had real support, not just sentiment.

With 1,661 million Class A shares and 158 million Class B shares outstanding (1,819 million total) as of June 30, 2025, and a quarter-end close of $29.96, that implies a market capitalization of approximately $54.5 billion - up from Q1's $39.6 billion on both the higher share price and modest share-count growth.

Using cash and cash equivalents of $6.796 billion against total debt of approximately $1.804 billion, net cash comes to roughly $4.992 billion, putting enterprise value at approximately $49.5 billion - up from Q1's $35.1 billion.

Market cap → enterprise value	Q2 2025
Share price (period-end)	$29.96
Shares outstanding (Class A + B)	1,819 million
Market capitalization	$54.5 billion
Net cash (cash & equivalents less total debt)	$4.992 billion
Enterprise value	$49.5 billion

EV/Revenue sanity check	Q1 2025	Q2 2025	Change
Enterprise value	$35.1 billion	$49.5 billion	up
EV/Revenue	1.13x	1.53x	up

• EV/Revenue^» using trailing-twelve-months revenue (FY2024's $30.268 billion minus H1 2024's $14.437 billion plus H1 2025's $16.432 billion, or $32.263 billion): ~1.53x, up from Q1's ~1.13x - breaking decisively out of the tight 1.1x-1.2x band the multiple had held for the prior two quarters.

DCF and reverse DCF (illustrative only): eighteen quarters of public-company data now cover Q3 2021 through Q2 2025. Checking this quarter against Q1 2025's base case:

Scenario	Assumption / outcome
Current (period-end close)	Actual EV/Revenue this quarter, for reference: 1.53x
Q1 2025 base case	The Q1 2025 base case called for the KFTC matters to continue without near-term resolution, Product Commerce's margin to hold around 8%, the buyback to go unused or be used modestly, and the multiple to stay flat in the 1.1x-1.2x band. Three of four landed close to base case - the KFTC matters remain unresolved (see Beyond the Usual), and the buyback went entirely unused, at the more conservative end of "unused or modest." But Product Commerce's margin didn't just hold at 8% - it jumped to a record 9.04%, and the multiple didn't stay flat - it broke out to ~1.53x, both well past the base case's range on the upside.
Bear case for next quarter	Bear case for next quarter: the September 2025 KFTC hearing or the October 2025 indictment hearing produces an adverse ruling, free cash flow's YoY decline (now four straight quarters of rising capex outpacing operating cash flow) continues to widen, and the multiple gives back some of this quarter's re-rating.
Base case for next quarter	Base case for next quarter: the KFTC matters continue without near-term resolution, Product Commerce's margin holds in the high-8s to 9% range, the buyback remains largely unused, and the multiple settles somewhere in the 1.3x-1.5x range after this quarter's sharp move.
Bull case for next quarter	Bull case for next quarter: Coupang begins actually executing against the $1 billion buyback authorization, Developing Offerings' losses resume narrowing after this quarter's sequential dip, free cash flow stabilizes as the fulfillment-center capex cycle matures, and the multiple holds or extends past 1.5x.

---